Literature DB >> 26992667

Decreased placental and maternal serum TRAIL-R2 levels are associated with placenta accreta.

Efser Oztas1, Sibel Ozler2, Ali Ozgur Ersoy2, Ebru Ersoy2, Ali Turhan Caglar2, Dilek Uygur2, Aykan Yucel2, Merve Ergin3, Nuri Danisman2.   

Abstract

OBJECTIVES: TNF-related apoptosis-inducing ligand receptor-2 (TRAIL-R2) is produced both by decidual and trophoblast cells during pregnancy and known to participate in apoptosis. In this study, we aimed to determine and to compare maternal serum and placental TRAIL-R2 levels in patients with placenta accreta, non-adherent placenta previa and in healthy pregnancies. We also aimed to analyze the association of placenta accreta with the occurrence of previous C-sections. STUDY
DESIGN: A total of 82 pregnant women were enrolled in this case-control study (27 placenta accreta patients, 26 non-adherent placenta previa patients and 29 age-, and BMI-matched healthy, uncomplicated pregnant controls). TRAIL-R2 levels were studied in both maternal serum and placental tissue homogenates. Determining the best predictor(s) which discriminate placenta accreta was analyzed by multiple logistic regression analyses. Adjusted odds ratios and 95% confidence intervals were also calculated.
RESULTS: Both placental and serum TRAIL-R2 levels were significantly lower in placenta accreta group (median 34.82 pg/mg and 19.85 pg/mL, respectively) when compared with both non-adherent placenta previa (median 39.24 pg/mg and 25.99 pg/mL, respectively) and the control groups (median 41.62 pg/mg and 25.87 pg/mL, respectively) (p < 0.05). Placental TRAIL-R2 levels and previous cesarean section were found to be significantly associated with placenta accreta (OR: 0.934 95% CI 0.883-0.987, p = 0.016 and OR:7.725 95% CI: 2.717-21.965, p < 0.001, respectively). Placental and serum TRAIL-R2 levels were positively correlated.
CONCLUSION: Decreased levels of placental TRAIL-R2 and previous history of cesarean section were found to be significantly associated with placenta accreta, suggesting a possible role of apoptosis in abnormal trophoblast invasion.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; Placenta accreta; TRAIL-R2

Mesh:

Substances:

Year:  2016        PMID: 26992667     DOI: 10.1016/j.placenta.2016.01.004

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  4 in total

Review 1.  Potential Serum Biomarkers in Prenatal Diagnosis of Placenta Accreta Spectrum.

Authors:  Tianyue Zhang; Shaowei Wang
Journal:  Front Med (Lausanne)       Date:  2022-05-30

Review 2.  Prevalence of abnormally invasive placenta among deliveries in mainland China: A PRISMA-compliant Systematic Review and Meta-analysis.

Authors:  Dazhi Fan; Song Li; Shuzhen Wu; Wen Wang; Shaoxin Ye; Qing Xia; Li Liu; Jinping Feng; Song Wu; Xiaoling Guo; Zhengping Liu
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

3.  Comparison between abdominal ultrasound and nuclear magnetic resonance imaging detection of placenta accreta in the second and third trimester of pregnancy.

Authors:  Hui Xia; Shu-Cheng Ke; Rong-Rong Qian; Ji-Guang Lin; Yang Li; Xia Zhang
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

4.  Integrative analysis provides multi-omics evidence for the pathogenesis of placenta percreta.

Authors:  Qingyuan Jiang; Lei Dai; Na Chen; Junshu Li; Yan Gao; Jing Zhao; Li Ding; Chengbin Xie; Xiaolian Yi; Hongxin Deng; Xiaodong Wang
Journal:  J Cell Mol Med       Date:  2020-10-21       Impact factor: 5.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.